Bionik Laboratories Launches Rental Financing Option for Healthcare Institutions

The Company in its commercialization process has determined that financing of Bionik Robotic Devices is an important option to provide to hospitals and other healthcare facilities.

TORONTO and BOSTON, March 21, 2017 -- Bionik Laboratories Corp. (BNKL) ("Bionik" or the "Company"), a global pioneering robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological disorders, announced today that it's partnering with a financing partner in order to offer a product rental program to make robotic rehabilitation products more affordable to health care institutions.

The Company in its commercialization process has determined that financing of Bionik Robotic Devices is an important option to provide to hospitals and other healthcare facilities. Bionik has now executed an agreement with a US Based finance partner that allows the Company to provide its products to hospitals and clinics on a rental basis within the United States. The program will assist healthcare providers in managing their costs, while allowing Bionik to provide offerings to a much larger customer base.
"Management is extremely pleased to launch this rental program," stated Mr. Peter Bloch, Chief Executive Officer and Chairman of the Board. "I firmly believe that this is an important step for us as an emerging medical device and robotics company. This program assists our customers with their budget constraints. We believe that this type of innovative financing for healthcare providers will allow robotic technologies to become more affordable to our healthcare provider partners and more accessible to those patients in need of assistance."
About Bionik Laboratories
Bionik Laboratories (BNKL), is a global, pioneering robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological disorders. The Company has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility impaired patients, including three products on the market and four products in varying stages of development. The InMotion Systems - the InMotion ARM™, InMotion Wrist™, InMotion Hand™ and InMotion AnkleBot™, are designed to provide intelligent, patient-adaptive therapy in a manner that has been clinically verified to maximize neuro-recovery. Bionik is also developing a lower-body exoskeleton, ARKE™, designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking. ARKE is expected to be designed to continually adapt to a patient's ability and provide real time feedback to the physiotherapist.
For more information, please visit www.bioniklabs.com and connect with us on Twitter, LinkedIn and Facebook.

Featured Product

SCHUNK's New Safety Gripping System EGN

SCHUNK's New Safety Gripping System EGN

With the SLS, SOS, and STO functionalities, the SCHUNK EGN gripping system certified in accordance with DIN EN ISO 13849 enables safe human/machine collaboration. If the production process is interrupted by an emergency shut-off, the SCHUNK EGN goes into either a safely limited speed mode or a safe stop mode depending on the activated protection zone. In contrast to other solutions available on the market, the SCHUNK safety gripping system is continuously powered even in the safe operating stop so that the gripped parts are reliably held even without mechanical maintenance of gripping force. As soon as the protection zone is released, the gripper immediately switches back to the regular operating mode without the system having to be restarted.